Description
Lonitab 5 MG Tablet | Patient & Clinical Guide to Oral Minoxidil
Lonitab 5 MG Tablet is an oral prescription medication containing 5 mg of Minoxidil. Manufactured by Intas Pharmaceuticals Ltd., it belongs to the pharmacological class of medications known as potassium channel openers and potent peripheral vasodilators.
Originally developed and indicated for severe, refractory hypertension (dangerously high blood pressure resistant to multi-drug therapy), oral Minoxidil in low-to-moderate doses like 5 mg is widely prescribed off-label by dermatologists and trichologists for the management of androgenetic alopecia (male and female pattern hair loss) and other resistant forms of alopecia.
It acts systemically to stimulate hair follicles, prolong the active hair growth phase, and increase follicle caliber.
Critical Medical Warning
Lonitab 5 MG is a systemic cardiovascular medication with potent blood-pressure-lowering and fluid-retention properties. It is a prescription-only drug that requires thorough cardiovascular assessment before initiation.
This guide is for educational purposes only and must not replace direct clinical consultation with a licensed physician, cardiologist, or dermatologist.
Biological Mechanism: How Oral Minoxidil Works
Unlike topical solutions that act locally where applied, oral Minoxidil is metabolized systemically to deliver its therapeutic actions.
Vascular and Cellular Pathways
-
Prodrug Activation: Following oral ingestion, Minoxidil is metabolized in the liver and target tissues (including the hair follicle outer root sheath) by the enzyme sulfotransferase (SULT1A1) into its active metabolite, minoxidil sulfate.
-
Potassium Channel Opening: Minoxidil sulfate opens adenosine triphosphate-sensitive potassium ($K_{\text{ATP}}$) channels in the cell membranes of vascular smooth muscle.
-
Hyperpolarization & Vasodilation: The opening of potassium channels causes cellular hyperpolarization, leading to the relaxation of arterial smooth muscle and significant dilation of peripheral arterioles.
-
Follicular Microcirculation: In the scalp, this systemic vasodilation improves microvascular perfusion around the dermal papilla, significantly increasing the delivery of oxygen, glucose, and essential growth factors to follicular cells.
-
Growth Cycle Modulation: Minoxidil prematurely shortens the telogen (resting) phase of the hair cycle, transitions dormant follicles into the anagen (active growth) phase, and lengthens anagen duration, leading to thicker and longer hair shafts.
Product Quick Summary
| Feature | Specification |
| Brand Name | Lonitab 5 MG Tablet |
| Active Ingredient | Minoxidil (5 mg per tablet) |
| Pharmacological Class | Direct-acting Peripheral Vasodilator / Channel Opener |
| Primary Indications | Refractory Hypertension (primary indication); Androgenetic Alopecia (off-label dermatological use) |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Form Factor | Swallowable oral tablet |
| Dosing Schedule | Once daily, as prescribed by a physician |
| Prescription Status | Prescription-only medicine (Schedule H) |
Clinical Comparison: Oral Minoxidil (Lonitab 5) vs. Topical Minoxidil Solution
| Parameter | Lonitab 5 MG Tablet (Oral) | Topical Minoxidil (5% Solution / Foam) |
| Route of Administration | Oral (swallowed with water) | Topical (applied to scalp twice daily) |
| Scalp Contact & Greasiness | None; zero scalp residue or styling impact | High; can cause residue, sticky hair, and scalp buildup |
| Scalp Irritation & Itching | Negligible local scalp contact dermatitis | High incidence (often due to propylene glycol vehicle) |
| SULT1A1 Enzyme Reliance | Relies on systemic/liver sulfotransferase enzymes | Relies strictly on scalp follicle sulfotransferase levels |
| Compliance & Ease of Use | High; single daily tablet | Moderate-to-low; requires disciplined application twice daily |
| Systemic Side Effect Risk | Higher (hypertrichosis, fluid retention, tachycardia) | Very low (minimal systemic absorption) |
Treatment Timeline & Regrowth Expectations (Dermatology)
When prescribed for hair loss, oral Minoxidil follows a biological progression:
-
Weeks 2 to 8 (The Dread Shed): Many patients experience an initial increase in hair shedding. This occurs because dormant telogen hairs are synchronized and shed to make way for active anagen hair growth. This shedding is temporary and considered a positive sign of drug responsiveness.
-
Months 2 to 4 (Stabilization): Hair shedding declines below pre-treatment levels. Hair strands begin to stabilize against premature falling.
-
Months 4 to 6 (Early Regrowth): Visible fine vellus hairs begin thickening and pigmenting along thinning regions (vertex/crown and mid-scalp).
-
Months 6 to 12 (Peak Density): Measurable increase in hair density, terminal hair diameter, and scalp coverage. Consistent daily intake is required to preserve these results.
Dosage, Administration & Safety Guidelines
-
Administration: Swallow the tablet whole with a full glass of water. Do not crush or chew it unless specifically instructed.
-
Timing: Take the tablet at the exact same time every day to maintain steady blood concentrations.
-
Food: May be taken with or without food.
-
Dose Splitting: For hair loss indications, dermatologists often start at lower doses (1.25 mg or 2.5 mg using a pill cutter, or escalating to 5 mg) to monitor cardiovascular tolerability. Follow your doctor’s dosing instructions precisely.
-
Missed Dose: Take the missed dose as soon as you remember, unless it is close to the next scheduled dose. Never take two tablets at once.
Potential Side Effects & Clinical Risks
Because Minoxidil is a systemic vasodilator, it can cause secondary hemodynamic and dermatologic effects:
Common Side Effects
-
Hypertrichosis: Increased growth, thickening, or darkening of fine body hair (face, forehead, arms, or back).
-
Temporary Hair Shedding: Initial shedding in the first few weeks of therapy.
-
Lightheadedness / Dizziness: Mild drops in resting blood pressure, especially when standing up quickly (orthostatic hypotension).
-
Headache: Due to vasodilation of cranial blood vessels.
Cardiovascular Warnings (Seek Medical Attention)
-
Reflex Tachycardia: Vasodilation triggers compensatory reflex sympathetic activation, causing rapid heart rate or palpitations.
-
Peripheral Edema & Fluid Retention: Retention of salt and water, leading to noticeable swelling of the lower legs, ankles, or feet.
-
Pericardial Effusion: In rare, severe instances, accumulation of fluid around the heart.
-
Sudden Unexplained Weight Gain: Rapid weight gain (e.g., 2–3 kg within a few days) indicates fluid retention.
Contraindications & Drug Interactions
Absolute Contraindications
-
Pheochromocytoma: Minoxidil stimulates catecholamine secretion and is contraindicated in patients with adrenal tumors.
-
Severe Cardiovascular Disease: Recent myocardial infarction (heart attack), severe ischemic heart disease, or uncompensated congestive heart failure.
-
Pulmonary Hypertension: Particularly when associated with mitral stenosis.
-
Pregnancy & Breastfeeding: Minoxidil crosses the placenta and passes into breast milk; it is contraindicated during pregnancy and lactation.
Significant Drug Interactions
-
Antihypertensives (e.g., Guanethidine): Co-administration can cause profound orthostatic hypotension and collapse.
-
Diuretics: Often co-prescribed in clinical hypertension to counteract fluid retention, but close electrolyte and hydration monitoring is required.
-
PDE5 Inhibitors (e.g., Sildenafil, Tadalafil): Concomitant use of vasodilators can lead to additive drops in blood pressure and syncope.
-
Alcohol: Alcohol exacerbates vasodilation, increasing the risk of acute dizziness, fainting, and low blood pressure.
Storage and Handling
-
Store in the original blister pack at room temperature between 15°C and 30°C (59°F to 86°F).
-
Keep away from excessive moisture, heat, and direct sunlight.
-
Store safely out of reach of children and domestic pets (Minoxidil is toxic to cats and dogs).
Frequently Asked Questions (FAQs)
Why prescribe Lonitab 5 MG for hair loss if it is a blood pressure drug?
Minoxidil was discovered to cause hypertrichosis (hair growth) as a secondary effect during clinical trials for high blood pressure. In low doses, dermatologists leverage this effect to stimulate hair follicles directly, bypassing issues associated with topical scalp irritation or poor topical response.
Will Lonitab 5 cause unwanted hair to grow on other parts of my body?
Hypertrichosis (fine hair growth on the face, arms, or back) is a known dose-dependent side effect of oral Minoxidil. If excessive hair growth occurs, physicians typically adjust the dosage or assess whether hair removal methods or discontinuation are appropriate.
What happens if I stop taking Lonitab 5 MG?
Minoxidil does not cure the underlying genetic cause of hair loss. If treatment is discontinued, the hair follicles will gradually return to their pre-treatment cycle within 3 to 6 months, and preserved or regrown hair will be shed.
Can I take Lonitab 5 MG alongside Finasteride?
Yes, under medical supervision. Minoxidil and Finasteride target different biological mechanisms: Minoxidil promotes vascular growth stimulation, while Finasteride inhibits DHT synthesis. They are frequently combined in clinical hair restoration protocols.
References
-
National Center for Biotechnology Information (NCBI):PubChem Compound Summary for CID 4201: Minoxidil. National Library of Medicine.
-
Drugs.com Professional Monograph:Minoxidil Clinical Drug Monograph: Actions, Dosing, and Safety Warnings.
-
Mayo Clinic Reference Library:Minoxidil (Oral Route) Proper Use, Cardiovascular Precautions, and Adverse Reactions.
-
U.S. Food and Drug Administration (FDA):Loniten (Minoxidil Tablets) Prescribing Information & Black Box Warnings.
Reviews
There are no reviews yet.